Tayyab S, Haq S K, Aziz M A, Khan M M, Muzammil S
Interdisciplinary Biotechnology Unit, Aligarh Muslim University, U.P. India.
Int J Biol Macromol. 1999 Nov;26(2-3):173-80. doi: 10.1016/s0141-8130(99)00074-4.
In order to study the involvement of lysine residues of human serum albumin (HSA) in the binding of indomethacin, HSA was treated with different molar excess of acetic anhydride, succinic anhydride and O-methylisourea which resulted in differently modified preparations: 30%, 62% and 87% acetylated, 20%, 34%, 64% and 78% succinylated and 21%, 43% and 86% guanidinated HSAs. All the preparations were found to be homogeneous with respect to charge as well as size as judged by polyacrylamide gel electrophoresis and gel filtration on a Seralose-6B column. Hydrodynamic and circular dichroic results showed that pronounced conformational changes (both tertiary and secondary structures) were induced in the maximally acetylated (87%) and succinylated (78%) preparations. On the other hand, guanidinated preparations showed no expansion in the hydrodynamic volume. The percent decrease in alpha-helical content was 34% for 87% acetylated, 31% for 78% succinylated and 10% for 86% guanidinated HSAs. A significant increase in the values of Stokes radii and frictional ratios (from 3.43 nm and 1.29 for native HSA to 4.07 nm and 1.52 for 87% acetylated and 4.35 nm and 1.60 for 78% succinylated HSAs, respectively) was also noticed in these highly modified preparations. Fluorescence quench titration results obtained at pH 7.4 and ionic strength 0.15 showed that only 54.1% and 64.7% binding of indomethacin at 4:1 drug/protein molar ratio was retained by 87% acetylated and 78% succinylated HSAs, respectively, as compared to 91% retention in binding in 86% guanidinated preparation. No reversal in the binding of drug to 87% acetylated and 78% succinylated HSA preparations was observed on increasing the ionic strength to 1.0. Therefore, it seems that one or two critical lysine residue(s) that can form salt linkage with the carboxyl group of indomethacin, was (were) probably modified in these preparations. A small decrease in the binding of drug to the guanidinated preparation also confirms the involvement of positive charge, probably contributed by lysine residue(s), in the binding of indomethacin to HSA.
为了研究人血清白蛋白(HSA)的赖氨酸残基在吲哚美辛结合中的作用,用不同摩尔过量的乙酸酐、琥珀酸酐和O-甲基异脲处理HSA,得到不同修饰的制剂:30%、62%和87%乙酰化,20%、34%、64%和78%琥珀酰化以及21%、43%和86%胍基化的HSA。通过聚丙烯酰胺凝胶电泳和在琼脂糖-6B柱上的凝胶过滤判断,所有制剂在电荷和大小方面均表现为均一。流体动力学和圆二色性结果表明,在最大程度乙酰化(87%)和琥珀酰化(78%)的制剂中诱导了明显的构象变化(包括三级和二级结构)。另一方面,胍基化制剂的流体动力学体积没有增大。对于87%乙酰化、78%琥珀酰化和86%胍基化的HSA,α-螺旋含量的降低百分比分别为34%、31%和10%。在这些高度修饰的制剂中还注意到斯托克斯半径和摩擦比的值显著增加(从天然HSA的3.43 nm和1.29分别增加到87%乙酰化的4.07 nm和1.52以及78%琥珀酰化的HSA的4.35 nm和1.60)。在pH 7.4和离子强度0.15下获得的荧光猝灭滴定结果表明,在药物/蛋白质摩尔比为4:1时,87%乙酰化和78%琥珀酰化的HSA分别仅保留了54.1%和64.7%的吲哚美辛结合,相比之下,86%胍基化制剂的结合保留率为91%。在将离子强度增加到1.0时,未观察到药物与87%乙酰化和78%琥珀酰化的HSA制剂的结合发生逆转。因此,似乎在这些制剂中可能修饰了一个或两个能够与吲哚美辛羧基形成盐键的关键赖氨酸残基。药物与胍基化制剂结合的小幅降低也证实了可能由赖氨酸残基贡献的正电荷在吲哚美辛与HSA结合中的作用。